KAI PHARMACEUTICALS, INC.
19Patents
18Active
19Granted
47Portfolio score
Filing activity: Sep 30, 2005 → Jun 21, 2017 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7265092B2 | Pharmaceutical formulation | Human Necessities | 23 | Expired |
| US8067532B2 | Modifications of peptide compositions to increase stability and delivery efficiency | Chemistry; Metallurgy | 21 | Active |
| US8623833B2 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Human Necessities | 15 | Active |
| US8987200B2 | Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders | Human Necessities | 8 | Active |
| US7727958B2 | Pharmaceutical formulation | Human Necessities | 8 | Active |
| US8377880B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 7 | Active |
| US8999932B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 6 | Active |
| US8278264B2 | Compositions and methods for enhancing drug delivery across and into ocular tissues | Human Necessities | 5 | Active |
| US9278995B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 4 | Active |
| US8969299B2 | Therapeutic agents for regulating serum phosphorus | Human Necessities | 4 | Active |
| US9701712B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 4 | Active |
| US8729010B2 | Compositions and methods for enhancing drug delivery across and into ocular tissues | Human Necessities | 4 | Active |
| US8524673B2 | Pharmaceutical formulation | Human Necessities | 4 | Active |
| US9255124B2 | Modifications of peptide compositions to increase stability and delivery efficiency | Chemistry; Metallurgy | 3 | Active |
| US9567370B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 1 | Active |
| US10280198B2 | Therapeutic agents for reducing parathyroid hormone levels | Human Necessities | 0 | Active |
| US8492346B2 | Methods of use of epsilon inhibitor compounds for the attenuation of pain | Chemistry; Metallurgy | 0 | Active |
| US8017583B2 | Methods of use of epsilon inhibitor compounds for the attenuation of pain | Chemistry; Metallurgy | 0 | Active |
| US10077438B2 | Modifications of peptide compositions to increase stability and delivery efficiency | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.